| 000 | 01437 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250515190035.0 | ||
| 264 | 0 | _c20091117 | |
| 008 | 200911s 0 0 fre d | ||
| 022 | _a0370-629X | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDugauquier, C | |
| 245 | 0 | 0 |
_a[Cerebral toxoplasmosis complicating an allograft with hematopoietic stem cells from peripheral blood]. _h[electronic resource] |
| 260 |
_bRevue medicale de Liege _c |
||
| 300 |
_a366-9 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; English Abstract; Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntiprotozoal Agents _xtherapeutic use |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFatal Outcome |
| 650 | 0 | 4 | _aHematopoietic Stem Cell Transplantation |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunocompromised Host |
| 650 | 0 | 4 |
_aLeukemia, Myeloid, Acute _xtherapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPyrimethamine _xtherapeutic use |
| 650 | 0 | 4 |
_aSulfadiazine _xtherapeutic use |
| 650 | 0 | 4 |
_aToxoplasma _xisolation & purification |
| 650 | 0 | 4 |
_aToxoplasmosis, Cerebral _xdiagnosis |
| 650 | 0 | 4 | _aTransplantation Conditioning |
| 650 | 0 | 4 | _aTransplantation, Homologous |
| 700 | 1 | _aBataille, Y | |
| 700 | 1 | _aWillems, E | |
| 700 | 1 | _aFrère, P | |
| 700 | 1 | _aDe Prijck, B | |
| 700 | 1 | _aBeguin, Y | |
| 700 | 1 | _aBaron, F | |
| 773 | 0 |
_tRevue medicale de Liege _gvol. 64 _gno. 7-8 _gp. 366-9 |
|
| 999 |
_c19174724 _d19174724 |
||